Clinical trial
Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy
NCT04402268 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy
- Lead sponsor
- Poznan University of Medical Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2014
- Completion date
- February 28, 2019
- Enrollment
- 252 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic cardiomyopathy